Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose vs Standard-dose Meglumine Antimoniate in Cutaneous Leishmaniasis
NCT00317980Phase 4Completed
- Sponsor
- University of Brasília
- Start
- Feb 2006
- Primary completion
- Mar 2008
- Countries
- 1
01
Overview
A Phase 4 trial of meglumine antimoniate in cutaneous leishmaniasis (CL), sponsored by University of Brasília. Started Feb 2006; status: completed.
02
Drugs
meglumine antimoniate
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on NCT00317980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00317980.